COVID-19 pneumonia Clinical Trials

10 recruitingLast updated: June 17, 2026

There are 10 actively recruiting covid-19 pneumonia clinical trials across 8 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 3. Top locations include Alexandroupoli, Greece, Athens, Greece, Brooklyn, New York, United States. Updated daily from ClinicalTrials.gov.


COVID-19 pneumonia Trials at a Glance

10 actively recruiting trials for covid-19 pneumonia are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Alexandroupoli, Athens, and Brooklyn. Lead sponsors running covid-19 pneumonia studies include KARE Biosciences, National Taiwan University Hospital, and Hellenic Institute for the Study of Sepsis.

Browse covid-19 pneumonia trials by phase

Treatments under study

About COVID-19 pneumonia Clinical Trials

Looking for clinical trials for COVID-19 pneumonia? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new COVID-19 pneumonia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about COVID-19 pneumonia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.

COVID-19 pneumoniaCardiovascular DiseasesPneumonia, Community-Acquired
Hellenic Institute for the Study of Sepsis650 enrolled18 locationsNCT06601998
Recruiting

Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors

COVID-19 pneumoniaCOVID-19 Respiratory InfectionCOVID-19+4 more
Weill Medical College of Cornell University510 enrolled3 locationsNCT05164744
Recruiting

Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine

SARS-CoV-2 virusCOVID-19 pneumoniaCOVID-19 Respiratory Infection+2 more
The Geneva Foundation100 enrolled1 locationNCT06402318
Recruiting
Not Applicable

Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19

COVID-19 pneumoniaAlcoholic Liver Disease
The Cleveland Clinic48 enrolled1 locationNCT04858412
Recruiting

Corona Virus Disease 2019 Cohort Study

COVID-19 pandemicCOVID-19 pneumoniaCOVID-19
Shandong University1,000 enrolled5 locationsNCT06927622
Recruiting

Retrospective Analysis of Chest X-ray Severity Scoring System of COVID-19 Pneumonia

COVID-19 pneumoniaSepsisPneumonia+2 more
Osijek University Hospital200 enrolled1 locationNCT05181696
Recruiting

AI-based System for Assessing Suspected Viral Pneumonia Related Lung Changes

COVID-19 pneumoniaPneumonia, Viral
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department563 enrolled1 locationNCT06501599
Recruiting

Clinical Characteristics and Long Term Impact on Pediatric COVID-19 in Taiwan

COVID-19 pneumoniaLong Covid19Multisystem Inflammatory Syndrome in Children
National Taiwan University Hospital3,000 enrolled1 locationNCT05582512
Recruiting
Phase 2Phase 3

Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia

COVID-19 pneumoniaCOVID-19 Respiratory Infection
KARE Biosciences324 enrolled7 locationsNCT05706454
Recruiting
Phase 1

Mesenchymal stromal cell (MSC) therapy for COVID-19 pneumonia

COVID-19 pneumonia
Royal Perth Hospital Cell & Tissue Therapies WA10 enrolled2 locationsACTRN12620000840987